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Background: Bacteria included in the genus Streptomyces exhibit several attractive characteristics that make them
adequate hosts for the heterologous expression of proteins. One of them is that some of its species have a high
secretion capacity and hence the protein of interest could be released to the culture supernatant, facilitating
downstream processing. To date, all the expression vectors described for these bacteria contain antibiotic resistance
genes as selection markers. However, the use of antibiotics to produce proteins at industrial level is currently
becoming more restricted owing to the possibility of contamination of the final product. In this report, we describe
the use of the S. lividans yefM/yoeBsl toxin-antitoxin system to develop a stable plasmid expression system.
Results: In order to use the yefM/yoeBsl system to stabilize expression plasmids in Streptomyces, a S. lividans mutant
strain that contained only the toxin gene (yoeBsl) in its genome and the antitoxin gene (yefMsl) located in a
temperature-sensitive plasmid was constructed and used as host. This strain was transformed with an expression
plasmid harbouring both the antitoxin gene and the gene encoding the protein of interest. Thus, after elimination
of the temperature-sensitive plasmid, only cells with the expression plasmid were able to survive. On using this
system, two proteins - an α-amylase from S. griseus and a xylanase from S. halstedii - were overproduced without
the addition of antibiotic to the culture medium. The production of both proteins was high, even after long
incubations (8 days), and after serial subcultures, confirming the stability of the plasmids without antibiotic
selection.
Conclusions: This is the first report that describes the use of a toxin-antitoxin system to maintain high -copy
plasmids in Streptomyces. This finding could be a valuable tool for using Streptomyces as a host to produce proteins
at the industrial and pharmaceutical levels without the use of antibiotics in the production step.
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The production of high levels of proteins for different pur-
poses (scientific, therapeutic, diagnostic, environmental,
agricultural, etc.) is one of the main goals of biotechnology
and the choice of a suitable expression system is a crucial
step in this process. Owing to its fast proliferation, high
expression levels and short fermentation time, Escherichia
coli is the host bacterium most commonly used for the
large-scale production of recombinant proteins [1]. How-
ever, E. coli is not always suitable for the production of ac-
tive proteins on account of problems of insolubility,
cytotoxicity, inefficient translation or the inability to carry* Correspondence: santa@usal.es
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reproduction in any medium, provided the orout post-translational modifications [2]. In order to over-
come these problems, other prokaryotic and eukaryotic
hosts have been used. Bacillus spp and Lactococcus are
Gram-positive bacteria that are often used to secrete pro-
teins into the culture medium [3-8]. Eukaryotic cells, such
as yeast cells, insect cells or immortalized cell lines, are
mainly used to produce active proteins with post-
translational modifications [9,10].
Streptomyces is a promising bacterial expression system
that has been used to produce high levels of several pro-
teins [1,11]. Streptomycetes are aerobic, filamentous
Gram-positive soil bacteria that secrete a wide range of
extracellular enzymes to degrade a broad variety of sub-
strates in order to survive.
As a host, Streptomyces has the following advantages
over other systems: 1) the formation of inclusion bodiesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suited host for the expression of very GC-rich genes
without codon adaptation [12]; 3) it has high protein se-
cretion efficiency, which makes it feasible to obtain the
protein of interest in the culture supernatant, facilitating
the protein folding and downstream procedures of ex-
traction and purification [11]; 4) the species used to ex-
press proteins (see below) display a relatively low level of
endogenous extracellular proteolytic activity in compari-
son with other hosts such as Bacillus, where deletion of
up to seven extracellular proteases had to be done to im-
prove protein production [13,14].S. lividans wt
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for producing recombinant proteins because it is genetic-
ally well characterized, it has low proteolytic activity and it
lacks the restriction systems present in other Streptomyces
species such as S. coelicolor. Accordingly, S. lividans can
be directly transformed with E. coli-derived shuttle vec-
tors. In fact, it has been used to produce a large number
of proteins of both prokaryotic and eukaryotic origin.
Most of them are summarized in two reviews [1,11].
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for the expression of genes from different Streptomyces
species, from Aspergillus nidulans and from Thermus
thermophilus ([12,16]). This system uses multi-copy mono-
functional (Streptomyces) or bi-functional (E. coli and
Streptomyces) plasmids that are selected with antibiotic re-
sistance genes (mainly thiostrepton or neomycin). How-
ever, the use of antibiotics at large-scale entails several
problems associated with the potential risk of contamin-
ation of the product, apart from its high cost. Moreover,
the use of antibiotics in intensive culture conditions is not
efficient owing to dilution or antibiotic inactivation [17,18].
This has made it necessary to develop alternative methods
to stabilize plasmid-bearing cultures without adding
antibiotics.
One alternative strategy is the use of toxin-antitoxin
(TA) systems that involve host death upon plasmid loss.
TA systems are widespread among the plasmids and ge-
nomes of bacteria and archaea and play important roles in
responses to environmental stress as well as in the stability
of mobile genetic material [19]. Class II TA systems con-
sist of a biologically active protein molecule (toxin) and
the corresponding inhibitor protein (antitoxin). The effi-
ciency of these TA systems depends on the different life-
span of both proteins; while toxins are highly resistant toS. lividans TA-pKC796
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(pGM160-YefMslTS) and S. lividans ΔTA-pKC796-TA(pGM160-YefMslTS) were uproteases, antitoxins have a very short half-life owing to
their high susceptibility to protease activity. Toxin activity
places cells in a dormant state, leading to cell death during
prolonged exposure. TA systems have been used for the
positive selection of transformants in E. coli [17,18,20].
Initially, the sequence encoding the full operon was in-
cluded in the expression plasmid and in plasmid-free cells
the antitoxin was degraded, leaving the toxin free to exert
its effect and causing cell death [21]. However, this system
can only delay the takeover of the culture by plasmid-free
cells because the dilution of the toxin, as a consequence of
bacterial growth, allows plasmid-free cells to survive. To
surmount these problems, other systems have been devel-
oped based on the separation of the two components of the
operon [17,18]. In these separate-component-stabilization
(SCS) systems, the antitoxin is localized in the plasmid and
the toxin is integrated in the bacterial chromosome. Thus,
when the plasmid is present in the cell, the antitoxin coun-
teracts the effect of the toxin, whereas upon plasmid loss
the toxin causes cell death.
Some of these systems based on the separation of the two
components of the operon are available commercially for
E. coli (StabyCloning™ and StabyExpress™, Delphi Genetics
SA). In these, the toxin gene (ccdB) is integrated into the
host chromosome and the antitoxin gene (ccdA) is inserted-pKC796-TA
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sion plasmid leads to cell death. They have been shown to
be effective for plasmid stabilization without the use of anti-
biotics during the production process [17,18,20].
By means of bioinformatics tools, up to 24 putative TA
systems have been identified in the S. coelicolor genome
(TADB) [22]. Our group has recently characterized the first
toxin/antitoxin system from Streptomyces experimentally
[23]. This system, from S. lividans, was named yefM/yoeBsl
and is identical to the system encoded by SCO2235/
SCO2236 from S. coelicolor (yefM/yoeBsc). In this system,
the toxin (YoeBsl) acts by inhibiting translation initiation
due to its mRNA interferase activity [23].
Here, we describe a new strategy for the stabilization of
expression plasmids in Streptomyces based on the use of
the yefM/yoeBsl system as a selection marker. In a first step,
we constructed the S. lividans host strain that contained
only the toxin gene (yoeBsl) in the chromosome, while the
antitoxin gene (yefMsl) was located in a temperature-
sensitive plasmid. This strain was used as a host to produce
proteins from an expression plasmid that contained both
the antitoxin gene and the gene of the protein of interest.
Thus, after removal of the temperature-sensitive plasmid
containing the antitoxin gene, the loss of the expression
plasmid led to cell death. This system was used to producexysApneo
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Figure 3 Enzyme production by the different strains. Amylase (A) and
ΔTA-pKC796 and S. lividans ΔTA-pKC796-Tox transformed with pNAnti-Amy
supplemented with 3% xylose. 10 μL of supernatant was loaded in each tratwo proteins without the use of antibiotics during the pro-
duction process. The production of both proteins remained
high even in long-term and serial cultures. These results
confirm the efficiency of the selection method as well as
the stability of the expression plasmids.
Results and discussion
Strategy
In the present work we developed a Streptomyces separate-
component-stabilization system with the yefM/yoeBsl TA
genes from S. lividans [23]. The strategy followed during
the work is summarized in Figure 1. In an initial step, we
deleted the complete yefM/yoeBsl operon from the genome
to obtain the S. lividans ΔTA strain (Figure 1 step 1); the
integration of yoeBsl into the chromosome of the ΔTA
strain was lethal [23]. Therefore, before integration of the
toxin we needed to transform this strain with an easily
removable plasmid containing the antitoxin. Thus, the S.
lividans-ΔTA strain was transformed with a temperature-
sensitive plasmid (pGM160 derivate [24]) containing the
antitoxin gene (Figure 1 step 2). Then, the toxin gene was
integrated in the genome with the integrative plasmid
pKC796-Tox [23] (Figure 1 step 3). This was the host strain
used to express proteins from plasmids selected with this
system (Figure 1 step 4).wt 
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Figure 4 Protein production in long time cultures without selection. Amylase (A) and Xylanase (C) production by S. lividans ΔTA-pKC796-Tox
transformed with pNAnti-Amy (A) and pNAnti-Xyl (C) after 4, 6 and 8 days of culture in YES medium supplemented with 3% xylose. 10 μL of
supernatant was loaded in each track. B and D show the percentage of amylase (B) and xylanase (D) activity of the supernatants. The histogram
bars are the mean of four experiments.
Sevillano et al. Microbial Cell Factories 2013, 12:39 Page 5 of 10
http://www.microbialcellfactories.com/content/12/1/39Host strain construction
S. lividans ΔTA was obtained by means of REDIRECT
technology, as previously described [23]. S. lividans ΔTA
protoplasts were transformed with the multicopy
temperature-sensitive thiostrepton resistance pGM160-
YefMslts plasmid [23], which expresses YefMsl (anti-
toxin) under the control of the strong Streptomyces
xysAp promoter [15,25]. The strain thus obtained was
designated S. lividans ΔTA(pGM160-YefMslts) (Figure 1).
Then, the yoeBsl (toxin) gene was integrated into the
genome of this strain with the pKC796-Tox plasmid [23] to
yield ΔTA-pKC796-Tox(pGM160-YefMslts). S. lividans ΔTA
(pGM160-YefMslts) protoplasts were also transformed
with the empty integrative pKC796 plasmid, generating
strain ΔTA-pKC796(pGM160-YefMslts), and with the plas-
mid containing the complete toxin-antitoxin operon,
pKC796-TA, generating strain ΔTA-pKC796-TA(pGM160-
YefMslts), which were used as controls. Viability studies
of these strains under different temperature conditions
(28 and 37°C) demonstrated that the S. lividans ΔTA strain
with the toxin gene integrated in the genome (ΔTA-
pKC796-Tox(pGM160-YefMslts)) was only viable at 28°C. It
was observed that, when this strain was spread onto R2YE
medium and incubated at 37°C the cells died because the
temperature-sensitive pGM160-YefMslts plasmid had beenlost (Figure 2). However, a few surviving colonies were ob-
served but these were not able to grow when they were
reinoculated onto patches on R2YE medium, suggesting an
accumulative effect of the toxin (data not shown). This
strain was therefore suitable for hosting the expression
plasmid, with the antitoxin gene as well as the gene encod-
ing the protein of interest. No toxic effect was observed
when plasmid pGM160-YefMslts was lost in the control
strains ΔTA-pKC796(pGM160-YefMslts) and ΔTA-pKC796-
TA(pGM160-YefMslts) when incubated at 37°C (Figure 2).
Effectiveness of the yefM/yoeBsl system as a plasmid
stabilization method
The efficiency of the yefM/yoeBsl system in the mainten-
ance of expression plasmids without antibiotic selection
was studied using the S. lividans ΔTA-pKC796-Tox
(pGM160-YefMslts) strain as host. The production of two
proteins - the Amy α-amylase from S. griseus IMRU3570
and the Xys1 xylanase from S. halstedii JM8 - was studied
in this strain and compared with the one obtained with
the wt-pKC796 and ΔTA-pKC796(pGM160-YefMslts)
strains, used as controls.
Plasmid pN702Gem3-Anti, a multicopy Streptomyces
plasmid that harbours the yefMsl gene under the control
of the xylanase promoter xysAp (see Methods), was used
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encoding the Amy α-amylase or the Xys1 xylanase under
the control of the pstSp promoter (see Methods).
Two plasmids, pNAnti-Amy and pNAnti-Xyl, were gen-
erated (see methods and Figure 3) and were used to trans-
form the S. lividans ΔTA-pKC796-Tox(pGM160-YefMslts)
strain and the S. lividans wt-pKC796 and S. lividans ΔTA-
pKC796(pGM160-YefMslts) control strains.
After removal of the temperature-sensitive plasmid
(pGM160-YefMslts) by incubation at 37°C (see Methods),
the transformants of S. lividans ΔTA-pKC796-Tox(pNAnti-
Amy), S. lividans ΔTA-pKC796-Tox(pNAnti-Xyl) and the
corresponding control strains obtained were grown without
antibiotics at 28°C in liquid YES medium supplemented
with 3% xylose (an inducer for xysA and pstS promoters).
The amount of amylase and xylanase in the supernatants
was analyzed by SDS-PAGE (Figure 3).
After 4 days of culture, strain ΔTA-pKC796-Tox pro-
duced high levels of amylase (pNAnti-Amy) and xylanase
(pNAnti-Xyl) (Figure 3A and B). However, no protein pro-
duction was observed in the control strains (wt-pKC796A
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Figure 5 Protein production after a freezing step of the mycelium. Am
transformed with pNAnti-Amy (A) and pNAnti-Xyl (C) before and after free
track. B and D show the percentages of amylase (B) and xylanase (D) activ
four experiments.and ΔTA-pKC796) transformed with the same plasmids.
These results indicated that the absence of antibiotic in
the culture medium was responsible for the loss of the ex-
pression plasmids (pNAnti-Amy or pNAnti-Xyl) in the
control strains that did not harbour the toxin in their ge-
nomes. On the contrary, the strain with the toxin gene in-
tegrated in the genome needed the presence of the
expression plasmid (in reality, the antitoxin gene present
in it) to live. Thus, even without antibiotics, this strain was
able to maintain the plasmids and, as consequence, pro-
duced high levels of proteins.
These results show that the separate-component-sta-
bilization strategy described in this work allows the over-
production of proteins without the addition of antibiotics
during the production step.
Plasmid stability
Plasmid stability without antibiotic selective pressure was
evaluated by analyzing the variations in protein produc-
tion under three different conditions: 1) long-term cul-
tures, 2) after freezing the mycelium and generating new0
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Figure 6 Protein production after serial subcultures. Amylase (A) and Xylanase (C) production by S. lividans ΔTA-pKC796-Tox transformed
with pNAnti-Amy (A) and pNAnti-Xyl (C) after three serial subcultures every two days (P1, P2, and P3) in fresh YES medium supplemented with
3% xylose. 10 μL of 4-day supernatants was loaded in each track. B and D show the percentage of amylase (B) and xylanase (D) activity of the
supernatants. The histogram bars are the mean of four experiments.
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liquid cultures.
The amount of protein produced in long-term cultures
was evaluated by SDS-PAGE and by assaying the enzym-
atic activities in the supernatants of S. lividans ΔTA-
pKC796-Tox transformed with pNAnti-Amy or with
pNAnti-Xyl. High amounts of both proteins were ob-
served even after 8 days of culture (Figure 4), suggesting
that the yefM/yoeBsl system allows stable maintenance
of the plasmids that express the amylase or the xylanase
in long-term cultures.
The stability of these plasmids after freezing the myce-
lium was studied by freezing two-day-old liquid culturesTable 1 Oligonucleotides used
Name Sequence 5′-3′ U
LS-005 TTTTTTCATATGTCCATCACCGCCAGCGAAG Fo
Th
LS-022 TTTTTTCTCGAGCGCCCGCTCCGCGTCCGGG Re
Th
MRG-11 TTTTTTCATATGGCCCGCAGACTCCGCACC Fo
Th
MRG-12 TTTTTTCTCGAGGCCGCGCCAGGTGTCGTTGAG Re
Thof S. lividans ΔTA-pKC796-Tox transformed with pNAnti-
Amy or with pNAnti-Xyl at −80°C in 20% glycerol. Frozen
cells were streaked out for single colonies on R2YE
medium without antibiotics, which were then reinoculated
on patches on new R2YE plates without antibiotics and
used to inoculate liquid YES medium with 3% xylose.
After 4 days of culture at 28°C, amylase and xylanase pro-
duction was analyzed by SDS-PAGE and measuring the
enzymatic activity of culture supernatants. The yield
obtained was compared with that achieved with the ori-
ginal 4-day-culture transformants (Figure 5). Over 90% of
amylase and xylanase activity persisted when the cultures
were set up from frozen mycelium (Figure 5B and D).se
rward oligonucleotide to amplify yefMsl.
e sequence recognized by NdeI is underlined.
verse oligonucleotide to amplify yefMsl.
e sequence recognized by XhoI is underlined.
rward oligonucleotide to amplify the amylase gene (amy) from S. griseus.
e sequence recognized by NdeI is underlined.
verse oligonucleotide to amplify the amylase gene (amy) from S. griseus.
e sequence recognized by XhoI is underlined.
Table 2 Plasmids used
Plasmid Characteristics Reference
pGM160 E.coli/Streptomyces shuttle vector. Thiostrepton and gentamicin resistance. [24]
pGM160-YefMsl pGM160 derivative. The xysA promoter from S. halstedii controls yefMsl expression. [23]
pKC796 E.coli/Streptomyces shuttle vector. Apramycin resistance. Integrative plasmid. [30]
pKC796-Tox pKC796 derivative. The xysA promoter from S. halstedii controls toxin expression. [23]
pKC796-TA pKC796 derivative. The xysA promoter from S. halstedii controls TA expression. [23]
pXHis1 pBluescript SK derivative. Ampicillin resistance. The xysA promoter from S. halstedii controls xys1Δ expression. [28]
pXHis1-Anti pXHis1 derivative. The xysA promoter from S. halstedii controls antitoxin expression. This work
pN702Gem3 E.coli/Streptomyces shuttle vector. Neomycin resistance. High-copy number. [29]
pN702Gem3-Anti pN702Gem3 derivative. The xysA promoter from S. halstedii controls antitoxin expression. This work
pNUF5 pN702Gem3 derivative. The pstS promoter from S. lividans controls xylanase expression. [31]
pNUF-Amy pNUF5 derivative. The pstS promoter from S. lividans controls amylase expression. This work
pNAnti-Xyl pN702Gem3-Anti derivative. The xysA promoter from S. halstedii controls antitoxin expression and the pstS promoter
from S. lividans controls xylanase expression.
This work
pNAnti-Amy pN702Gem3-Anti derivative. The xysA promoter from S. halstedii controls antitoxin expression and the pstS promoter
from S. lividans controls amylase expression.
This work
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selection was assessed by serial 100-fold dilutions of cul-
tures in fresh YES medium every 48 hours over 6 days.
The amylase and xylanase activities of each subculture
were analyzed in the supernatants and compared with
the enzymatic activity obtained in the original culture
(Figure 6). The amylase activity obtained after three
rounds of subculture was 90% of the original culture ac-
tivity (Figure 6B). Xylanase production was also high
throughout the experiment but a loss of xylanase activity
was observed in the third subculture, where it was 70%
of that obtained in the original culture (Figure 6D).
These data show that the toxicity of the product of the
integrated toxin gene (yoeBsl) in the genome of the host
strain (S. lividans ΔTA-pKC796-Tox(pNAnti-“prot”)) is
able to allow stable maintenance of the multicopy expres-
sion plasmids carrying the antitoxin gene (yefMsl) and the
gene encoding the protein of interest (pNAnti-“prot”).
Conclusions
In this work, we report a new method that allows the
production of high levels of proteins in Streptomyces
without the use of antibiotics during the production
step. This new system is based on the separation of the
toxin gene (localized in the genome) and antitoxin gene
(localized in the expression plasmid) of the yefM/yoeBsl
operon from S. lividans.
The system was found to be useful for the production
of high yields of two proteins and could be a powerful
tool for producing other proteins of interest in Strepto-
myces without the drawbacks associated with the use of
antibiotics in the production step. This work constitutes
the first application of a toxin-antitoxin system to select
and stabilize plasmids in Streptomyces.Methods
Bacterial strains and growth conditions
The E. coli DH5α strain [26] was used for the cloning
and isolation of plasmids. All strains were grown in
Luria-Bertani (LB) liquid broth or on LB agar. All ma-
nipulations in E. coli were performed following standard
procedures [26].
Protoplasts of S. lividans 1326 and S. lividans ΔTA
(ΔyefM/yoeBsl) were grown on solid R2YE medium after
transformation [27]. MSA medium was used for Streptomy-
ces sporulation [27], and liquid YES medium (1% yeast ex-
tract, 10.3% sucrose pH 7.2, 5 mM MgCl2), supplemented
with 0.5% glucose and 0.5% glycine for collecting cells to
generate protoplasts, and YES medium supplemented with
3% xylose for protein expression were used. Liquid cultures
were carried out in baffled flasks at 28°C and 200 rpm. All
manipulations in Streptomyces were done as indicated by
Kieser [27].
Transformation of host strain and colony selection
Protoplast of S. lividans ΔTA-pKC796-Tox(pGM160-
YefMsl) and the control strains, S. lividans wt-pKC796
and S. lividans ΔTA-pKC796(pGM160-YefMsl) were
transformed with the expression plasmids. After trans-
formation, protoplasts were regenerated o/n at 28°C,
then overlayed with 50 μg/mL neomycin to select the
cells transformed with the expression plasmids and trans-
ferred to 37°C for 3 days to eliminate the temperature-
sensitive plasmid (pGM160-YefMsl). The loss of the
temperature-sensitive plasmid (pGM160-YefMsl) in these
transformants colonies was checked by replica-plating the
clones onto R2YE plates with 10 μg/mL thiostrepton. Fi-
nally, the clones were reinoculated on patches on R2YE
plates without antibiotics and incubated at 28°C.
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pN702Gem3-Anti
yefMsl was amplified by PCR from S. lividans 1326 gen-
omic DNA using primers LS-005 and LS-022 (Table 1).
The resulting fragment was digested with NdeI and XhoI
and ligated into plasmid pXHis1 [28] (Table 2) digested
with the same enzymes to obtain plasmid pXHis1-Anti,
which was used as an intermediate plasmid. Plasmid
pN702Gem3-Anti was obtained by digesting pXHis1-Anti
with BglII, purifying the corresponding yefMsl band and li-
gating it into pN702Gem3 [29] digested with the same en-
zyme. In this plasmid, the antitoxin (yefMsl) gene is
regulated by the xysA promoter [15,25].pNAnti-Xyl
This plasmid contained the ORF of the xylanase xysA gene
from S. halstedii under the control of the pstS promoter
and the ORF coding for the antitoxin (YefMsl) under the
control of the xysA promoter. The plasmid was originated
from the pNUF5 plasmid [31], which contains the xylanase
gene regulated by pstSp; pNUF5 was digested with BglII
and BamHI, and the xysA gene band was ligated into
pN702Gem3-Anti digested with BamHI.
pNUF-Amy
The amylase gene (amy) from S. griseus IMRU 3570 [32]
was amplified by PCR using primers MRG-11 and
MRG-12 (Table 1). The resulting fragment was digested
with NdeI and XhoI and, in different steps, was intro-
duced into pNUF5 downstream the pstS promoter.
pNAnti-Amy
This plasmid contains the ORF of the amylase gene from
S. griseus under the control of the pstS promoter and the
ORF coding for the antitoxin (YefMsl) under the control
of the xysA promoter. To construct the plasmid, plasmid
pNUF-Amy, which contains the amylase gene regulated
by pstSp, was digested with BglII and BamHI and the
corresponding band was ligated into pN702Gem3-Anti
digested with BamHI.
Sequence analyses
All constructions were sequenced in both strands using
a Perkin Elmer ABI Prism 377 DNA sequencer. In silico
plasmids were obtained with the Gene Construction Kit
software (GCK, Textco).
Protein analyses
Protein profiles were analyzed by denaturing polyacryl-
amide gel electrophoresis (SDS-PAGE) in a MiniProtean
II system (Bio-Rad). Proteins were detected by 0.5%
Coomassie brilliant blue R staining and low-molecular
weight standards from Bio-Rad were used as markers.Xylanase and amylase activities assays
Xylanase and amylase activities were measured with the
dinitrosalicylic acid (DNS) method, using xylose or mal-
tose as standards respectively [33]. One unit of xylanase or
amylase activity was defined as the amount of enzyme re-
quired to release 1 μmol of reducing sugars in one minute
(expressed as xylose or maltose equivalents respectively).
All data shown are means of at least three different
experiments.
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